These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1985206)

  • 1. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences.
    Thornell A; Hallberg B; Grundström T
    J Virol; 1991 Jan; 65(1):42-50. PubMed ID: 1985206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.
    Hallberg B; Schmidt J; Luz A; Pedersen FS; Grundström T
    J Virol; 1991 Aug; 65(8):4177-81. PubMed ID: 1649324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEF1 binding is important for T cell specific enhancers of genes for T cell receptor-CD3 subunits.
    Hallberg B; Thornell A; Holm M; Grundström T
    Nucleic Acids Res; 1992 Dec; 20(24):6495-9. PubMed ID: 1480471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.
    Zaiman AL; Lewis AF; Crute BE; Speck NA; Lenz J
    J Virol; 1995 May; 69(5):2898-906. PubMed ID: 7707514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3.
    Thornell A; Hallberg B; Grundström T
    Mol Cell Biol; 1988 Apr; 8(4):1625-37. PubMed ID: 2837650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of SEF1 proteins binding to transcriptional enhancer elements active in T lymphocytes.
    Thornell A; Holm M; Grundström T
    J Biol Chem; 1993 Oct; 268(29):21946-54. PubMed ID: 8408051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CBF, Myb, and Ets binding sites are important for activity of the core I element of the murine retrovirus SL3-3 in T lymphocytes.
    Zaiman AL; Nieves A; Lenz J
    J Virol; 1998 Apr; 72(4):3129-37. PubMed ID: 9525638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
    Ethelberg S; Hallberg B; Lovmand J; Schmidt J; Luz A; Grundström T; Pedersen FS
    J Virol; 1997 Feb; 71(2):1196-206. PubMed ID: 8995642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers.
    Corneliussen B; Thornell A; Hallberg B; Grundström T
    J Virol; 1991 Nov; 65(11):6084-93. PubMed ID: 1681116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
    Zaiman AL; Lenz J
    J Virol; 1996 Aug; 70(8):5618-29. PubMed ID: 8764076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased induction of osteopetrosis, but unaltered lymphomagenicity, by murine leukemia virus SL3-3 after mutation of a nuclear factor 1 site in the enhancer.
    Ethelberg S; Tzschaschel BD; Luz A; Diaz-Cano SJ; Pedersen FS; Schmidt J
    J Virol; 1999 Dec; 73(12):10406-15. PubMed ID: 10559359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
    Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
    J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells.
    LoSardo JE; Cupelli LA; Short MK; Berman JW; Lenz J
    J Virol; 1989 Mar; 63(3):1087-94. PubMed ID: 2644446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats.
    Morrison HL; Dai HY; Pedersen FS; Lenz J
    J Virol; 1991 Feb; 65(2):1019-22. PubMed ID: 1846181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements.
    Marine J; Winoto A
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7284-8. PubMed ID: 1871134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.
    Nieves A; Levy LS; Lenz J
    J Virol; 1997 Feb; 71(2):1213-9. PubMed ID: 8995644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.
    Tupper JC; Chen H; Hays EF; Bristol GC; Yoshimura FK
    J Virol; 1992 Dec; 66(12):7080-8. PubMed ID: 1331510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.
    Martiney MJ; Levy LS; Lenz J
    J Virol; 1999 Mar; 73(3):2143-52. PubMed ID: 9971797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
    Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
    J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Various modes of basic helix-loop-helix protein-mediated regulation of murine leukemia virus transcription in lymphoid cell lines.
    Nielsen AL; Nørby PL; Pedersen FS; Jørgensen P
    J Virol; 1996 Sep; 70(9):5893-901. PubMed ID: 8709209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.